The efficacy of switching basal-bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching
对于2型糖尿病患者，从基础-餐时胰岛素治疗方案转换为以格列奈类药物和α-葡萄糖苷酶抑制剂为基础胰岛素支持的口服降糖药治疗方案的疗效取决于胰岛素分泌能力，而非转换前的血糖水平和胰岛素剂量。
期刊:Diabetology International
影响因子:1.2
doi:10.1007/s13340-023-00651-z
Ando, Toshihito; Kondo, Masaki; Asada-Yamada, Yuriko; Kawai, Miyuka; Asano-Hayami, Emi; Hayami, Tomohide; Motegi, Mikio; Ejima, Yohei; Nagao, Eriko; Kasagi, Rina; Nakai-Shimoda, Hiromi; Asano, Saeko; Kato, Makoto; Yamada, Yuichiro; Yura-Miura, Emiri; Ishikawa, Takahiro; Sugiura-Roth, Yukako; Kojima, Chika; Naito, Ena; Himeno, Tatsuhito; Tsunekawa, Shin; Kato, Yoshiro; Nakamura, Jiro; Kamiya, Hideki
